成人复发岛叶弥漫性胶质瘤清醒切除的可行性、安全性和影响
该单中心回顾性队列分析(2010-2023年)纳入123例成人岛叶弥漫性胶质瘤清醒手术患者,比较一线手术(n=87)与复发手术(n=36)。复发组术中不良事件未增加,切除率与一线手术相似(中位数91.9% vs 90.1%),但既往联合肿瘤治疗者术中配合不足率(33.3%)高于单模式治疗者(7.4%)和一线手术者(8.1%,P = .046)。
要点
- 复发岛叶弥漫性胶质瘤清醒切除术中不良事件与一线手术相比未增加。
- 既往联合肿瘤治疗者术中配合不足率为33.3%,高于单模式治疗的7.4%和一线手术的8.1%(P = .046)。
- 复发组切除率中位数91.9%与一线组90.1%相似,手术并发症和住院时间未增加。
核心结论
- 基于功能的经岛盖清醒切除术在既往治疗过的岛叶弥漫性胶质瘤复发时似乎可行且安全,切除率和结局与初次手术相似。
研究设计与样本
- 观察性、回顾性、单中心队列分析(2010-2023年),纳入123例连续成人岛叶弥漫性胶质瘤(2021年世界卫生组织分类)清醒手术患者。
- 比较一线清醒切除组(n = 87)与既往治疗后复发清醒切除组(n = 36)。
主要发现
- 复发岛叶弥漫性胶质瘤经岛盖清醒切除术与一线切除相比,术中不良事件未增加。
- 既往联合肿瘤治疗者术中配合不足率为33.3%,高于既往单模式治疗者的7.4%和一线手术者的8.1%(P = .046)。
- 复发组切除率与一线手术相似,中位数91.9% vs 90.1%。
- 复发手术未增加手术相关并发症或住院时间,未恶化6个月Karnofsky体能状态评分、癫痫控制或病假。
- 复发手术未影响6个月因病请假,但在高级别胶质瘤患者中与更长病假相关(38.0% vs 7.7%,P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The risk-to-benefit ratio of transopercular awake resection for recurrent insular diffuse gliomas is poorly studied. We assessed feasibility, safety, and efficacy of awake surgical resection of recurrent insular diffuse gliomas in patients with previous treatments (resection and/or radiotherapy and/or chemotherapy and/or combination). METHODS: Observational, retrospective, single-institution cohort analysis (2010-2023) of 123 consecutive adult patients operated on for an insular diffuse glioma (2021 World Health Organization classification) under awake conditions. Comparison between awake resection for an insular diffuse glioma as first-line treatment (n = 87) and after previous treatments (n = 36). RESULTS: Function-based transopercular awake resection for a recurrent insular diffuse glioma (1) did not increase intraoperative adverse events compared with first-line resection; (2) was associated with a higher rate of intraoperative insufficient cooperation in patients with a previous combined oncological treatment (33.3%), compared with patients with a previous monotherapeutic modality (7.4%), and compared with patients with a first-line surgery (8.1%, P = .046); (3) resulted in resection rates similar to those of awake resection at first-line surgery (median 91.9%, vs 90.1%); (4) did not increase surgery-related complications or duration of hospital stay; (5) did not worsen the 6-month Karnofsky Performance Status score, seizure control, and sick leave; (6) did not influence the 6-month sick leave from work, but was associated with longer sick leave in patients with high-grade gliomas (38.0% vs 7.7%, P < .001). CONCLUSION: Function-based transopercular awake resection seems feasible and safe at recurrence of a previously treated insular diffuse glioma, with similar resection rates and outcomes than first-time surgery.
引用
- Demasi M, Elia A, Simboli GA, et al. Feasibility, Safety, and Impact of Awake Resection for Recurrent Insular Diffuse Gliomas in Adults. Neurosurgery. 2025. PMID: 39878468. doi:10.1227/neu.0000000000003366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。